Shanti Pharmaceuticals’ Post

🌍 “Towards a Malaria-Free World: Our Commitment to Health Equity” 🌍 In this ever-evolving battle against malaria, our company stands at the forefront, delivering effective and affordable antimalarials to vulnerable populations. Since 1999, we’ve introduced 11 new antimalarials, saving an estimated 2.7 million lives. But the fight isn’t over—409,000 deaths still occur worldwide from malaria each year. On this World Malaria Day, let’s celebrate our progress and reaffirm our dedication to eradicating this disease. Together, we can empower communities, mobilize resources, and ensure that zero malaria starts with all of us. Are you someone looking for buying anti-malarial drugs such as, 👉 Alpha Beta Arte ether 75 Mg / 150 Mg / 225 Mg Tablets 👉 Artemether 20 / 40 / 80mg + Lumefantrine 120 / 240 / 480mg Tablets 👉 Chloroquine Phosphate Tablets 250 / 500 Mg Visit us at www.vaishalipharma.com or drop us a mail of your B2B enquiries at exports@vaishalipharma.com

#grrf Special Day Update 25 April – World Malaria Day World Malaria Day, which takes place on 25 April each year, is an internationally recognized day, highlighting the global efforts to control malaria and celebrating the gains that have been made. Since 2000, the world has made historic progress against malaria, saving millions of lives. However, half the world still lives at risk from this preventable, treatable disease, which costs a child’s life every two minutes. El Salvador is the third country to have achieved malaria-free status in recent years in the WHO Region of the Americas, following Argentina in 2019 and Paraguay in 2018. Seven countries in the region were certified from 1962 to 1973. Globally, a total of 38 countries and territories have reached this milestone. India is NOT featured in this list. A total of 3, 38,494 cases and 77 deaths were reported in 2019 in India. This day aims to reduce malaria cases and deaths due to it. #grrf #malaria #disease #who #preventable #health #people

📢 Brazil and Thailand become the first malaria-endemic countries to launch new single-dose relapse prevention medicine for Plasmodium vivax (P. vivax) malaria    P. vivax is the dominant malaria parasite in many countries outside of sub-Saharan Africa and is characterised by clinical relapses. Without treatment for the latent liver-stage infection, patients experience repeated bouts of illness, imposing significant physical, economic, and social burdens on both individuals and communities. Relapses also increase the disease burden and the potential for onward transmission, ultimately impeding global efforts to eliminate malaria.     Developed through a longstanding partnership Medicines for Malaria Venture, tafenoquine, co-administered with chloroquine, offers a new potential treatment option for vulnerable populations who are disproportionately affected by this disease.     By continuing to invest in global health R&D, strengthening healthcare systems, and enabling access to healthcare in lower-income countries, together with our partners we can help change the trajectory of malaria.    #ChangeTheTrajectory #Malaria #GlobalHealth #ZeroMalaria 

Hoping this launch of the new drug, tafenoquine co-administered with cholroquinone can help eliminate the endemic faced by the countries affected. Even though the target for this drug is specific for Plasmodium vivax, there are many more types Plasmodium that causes malaria like P. ovale, P. falciparum, P. knowlesi and P. malariae. These are the most common types of Plasmodium species known to cause malaria. Looking forward for future R&D of new drugs in targeting these parasites. Well done GSK! #eliminatemalaria

Collaboration is essential to lead change. Only with the help of different agents, can we become stronger and find solutions to one of the most prevailing diseases: malaria. Most prominent in Asia and South America, it is the cause of around 700.000 deaths a year, and that is why we need innovative approaches focused on prevention and the integration of new treatments, vaccines, and diagnostics to control and eliminate this condition. At One Against Malaria, we are committed to developing and facilitating access to new therapeutic solutions that block transmission of the disease and prevent infection. Only through such initiatives promoted by Merck Healthcare, as well as increased investment in research, that we will help the most vulnerable regions to eradicate the disease and improve the health of their populations. Urgent action is needed to tackle this health and social problem in order to reach the World Health Organisation's goal of zero malaria by 2025. Together, we are making science work for life and health. https://lnkd.in/dm3rxyb9 #WorldMalariaDay #EndMalaria

World Malaria Day, Medec Medicare Ltd reaffirms its unwavering commitment to combating malaria and improving global health outcomes. Malaria continues to pose a significant threat to communities worldwide, especially in regions with limited access to healthcare resources. As a pharmaceutical company dedicated to making a positive impact, we recognize the urgent need for innovative solutions to address this preventable and treatable disease. At Medec Medicare Ltd, we are proud to contribute to the fight against malaria through our ongoing research, development, and collaboration efforts. From pioneering antimalarial medications to supporting initiatives for vector control and public health education, we are actively working towards a malaria-free future. On this important day, let us unite in our efforts to raise awareness, drive innovation, and ensure access to life-saving interventions for those affected by malaria. Together, we can make a difference and move closer to our shared goal of eradicating malaria for good. Join us in advocating for #MalariaAwareness and together, let's build a healthier, malaria-free world. 🦟💊🌍 #WorldMalariaDay #GlobalHealth #MedecMedicare #PublicHealth #EndMalaria

World Malaria Day, observed annually on April 25, serves as a global tribute to the collective endeavors to combat malaria. As stated by the World Health Organization (WHO) : - In 2022, there were 608,000 reported malaria-related fatalities - The year 2022 also witnessed 249 million new malaria cases. - A staggering 94% of all malaria incidents occurred within the WHO African Region. On this World Malaria Day, let us unite under the theme of "Accelerating the battle against malaria for a fairer world" by advocating for the provision of healthcare services closer to communities, thereby enhancing access through primary healthcare initiatives. RBM Partnership to End Malaria #WorldMalariaDay #WorldMalariaDay2024

😔Reflecting on World Malaria Day, April 25th, it's crucial to recognize the persistent threat of malaria and its devastating impact on global health, particularly on children's mortality rates. Did you know that malaria remains a leading cause of death among children under the age of five in many parts of the world? ✨️As the former Program Lead at CHAI on the malaria program, I witnessed firsthand the tireless efforts and dedication of individuals and organizations working tirelessly to combat this disease. 🚀 Despite progress in recent years, malaria still affects millions of people worldwide, with ↗️ over 200 million cases reported annually. Malaria not only poses a significant health risk but also imposes an economic burden on communities and countries affected by the disease. 💱 The costs associated with treatment, loss of productivity, and healthcare infrastructure strain underscore the urgency of our collective action. ❇️However, amidst these challenges, there is hope. Through sustained investment in prevention, treatment, and research, we can make significant strides towards eliminating malaria. From mosquito nets to innovative treatments, every effort counts in the fight against this preventable and treatable disease. 🔆⚛️ On this World Malaria Day, let's renew our commitment to ending malaria for good. Together, we can create a healthier, malaria-free future for generations to come. #WorldMalariaDay #EndMalaria #iealmpactConsulting

Creating Impact | Working for a Malaria-Free Future this World Malaria Day and Beyond www.sidc.care Today, on World Malaria Day, we unite in our commitment to combat one of the world's oldest and deadliest diseases. Malaria continues to claim far too many lives, especially in vulnerable communities globally. At SIDC Diagnostics, we recognize the urgent need for action. Malaria is preventable and treatable, yet it remains a significant global health challenge. As professionals dedicated to positive change, let's utilize our platforms to raise awareness about prevention, early diagnosis, and effective treatment options. By supporting initiatives like those at SIDC Diagnostic Center, aimed at ending malaria, we contribute to creating a healthier, more resilient world. Let's amplify our efforts, share knowledge, and advocate for increased access to life-saving interventions. Join us in the fight against malaria. Together, we can make a tangible difference and strive towards a malaria-free future. #WorldMalariaDay #EndMalaria

🦟 Addressing Malaria Management Challenges 🌍 Managing malaria presents complex hurdles globally. From limited access to healthcare in certain regions to evolving drug resistance, the fight against this disease demands collaborative solutions. Let's join hands, share insights, and work towards a world where malaria is no longer a threat. Together, we can make a difference! #MalariaManagement #GlobalHealth #PublicHealth #CollaborationNeeded